SCHEMBL8875368

SCHEMBL8875368

Cc1c(-c2ccccc2)oc2c(CC(=O)O)cccc2c1=O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GLA P06280 2/20 0.63
▸ STING1 Q86WV6 1/20 0.63
▸ LMNA P02545 6/20 0.54
▸ MAPT P10636 5/20 0.54
▸ SMN1; SMN2 Q16637 4/20 0.54
▸ NPSR1 Q6W5P4 3/20 0.54
▸ GAA P10253 1/20 0.54
▸ ALDH1A1 P00352 7/20 0.50
▸ KDM4E B2RXH2 2/20 0.50
▸ CYP3A4 P08684 2/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CHRM2 P08172 1/20 0.50
▸ HTR1A P08908 1/20 0.50
▸ ADRA2A P08913 1/20 0.50
▸ ADORA3 P0DMS8 1/20 0.50
▸ CYP2D6 P10635 1/20 0.50
▸ CHRM1 P11229 1/20 0.50
▸ ACHE P22303 1/20 0.50
▸ SLC6A2 P23975 1/20 0.50
▸ PDE4A P27815 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9550449 0.91 GLA (0.56) GLASTING1LMNAMAPTSMN1; SMN2
SCHEMBL5118184 0.88 LMNA (0.54) GLASTING1LMNAMAPTSMN1; SMN2
SCHEMBL14266220 0.86 LMNA (0.55) GLASTING1LMNAMAPTSMN1; SMN2
SCHEMBL12835532 0.85 ABCG2 (0.59) GLASTING1LMNAMAPTSMN1; SMN2
SCHEMBL8874632 0.84 LMNA (0.50) GLASTING1LMNAMAPTSMN1; SMN2
SCHEMBL5116298 0.84 LMNA (0.50) GLASTING1LMNAMAPTSMN1; SMN2
SCHEMBL12835497 0.84 ABCG2 (0.60) GLASTING1MAPTGAAALDH1A1
SCHEMBL8875855 0.82 LMNA (0.48) GLASTING1LMNAMAPTSMN1; SMN2
SCHEMBL8876534 0.81 AURKA (0.49) GLASTING1LMNAMAPTSMN1; SMN2
SCHEMBL8875205 0.80 ALDH1A1 (0.49) GLASTING1LMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114736183-B Preparation method of 3-methyl flavone-8-carboxylic acid 迪嘉药业集团股份有限公司 2023-10-17 — — CN disclosed
CN-114736183-A Preparation method of 3-methylflavone-8-carboxylic acid 迪嘉药业集团有限公司 2022-07-12 — — CN disclosed
CN-1040434-C Heterobicyclic compounds RECORDATI CHEM PHARM (CH) 1998-10-28 — — CN disclosed
US-5605896-A Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities RECORDATI S.A., CHEMICAL AND PHARMACEUTICAL COMPANY (CH) 1997-02-25 — — US disclosed
US-5474994-A Treating hypertension, urethral and lower urinary tract contractions RECORDATI S.A., CHEMICAL AND PHARMACEUTICAL COMPANY (CH) 1995-12-12 — — US disclosed
US-5403842-A Adrenergic blocking and antiserotonine agents; urogenital disorders including spasms of the urethral tract and prostrate problems RECORDATI S.A., CHEMICAL AND PHARMACEUTICAL COMPANY (CH) 1995-04-04 — — US disclosed
CN-1079738-A Heterobicyclic compounds RECORDATI CHEM PHARM (CH) 1993-12-22 — — CN disclosed
WO-1993017007-A1 HETEROBICYCLIC COMPOUNDS RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A. (IT) 1993-09-02 — — WO disclosed
EP-0558245-A1 Heterobicyclic compounds as antagogists of alpha-1 adrenergic and SHT1A receptors RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY (CH) 1993-09-01 — — EP disclosed
Send feedback